There are currently therapies for 5% of hereditary diseases - This figure will continue to rise as gene and cell therapies are developed - Gene therapy involves transferring DNA fragments to restore a defective cell function and to alleviate the symptoms of a disease - Researchers with more than 25 years of proven experience in ocular genetics - The EYE is the organ of choice for studying gene therapies - DBGen is a spin-off that was created by a research group at the University of Barcelona - DBGen includes specialists in: Human genetics, Bioethics, Business administration, Science outreach